AEVI GENOMIC Revenue, Profits - GNMX Quarterly Income Statement

Add to My Stocks
$1.14 $0.08 (6.56%) GNMX stock closing price Jun 21, 2018 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking AEVI GENOMIC stock price alone is not sufficient. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the GNMX stock is bound to reflect the impact of the QOQ decline of 0. Revenue for year 2018 Q1 is $- and has decreased from $- quarter on quarter as is evident when you compare the latest figures in the latest AEVI GENOMIC profit and loss statement with those of the prior corresponding period. Also see AEVI GENOMIC assets and AEVI GENOMIC free cash flow for a complete valuation of GNMX stock.

View and download details of revenue and profits for AEVI GENOMIC for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
AEVI GENOMIC Revenues or Net Sales
Cost Of Goods Sold (COGS)----------
Research & Development Expense6.56M5.28M6.29M5.66M7.94M5.14M7.52M8.74M6.95M4.32M
Selling General & Admin Expense2.17M1.91M2.27M2.36M2.98M3.35M3.04M2.94M4.19M2.14M
Income Before Depreciation Depletion Amortization-8.73M-7.18M-8.56M-8.03M-10.93M-8.48M-10.57M-11.68M-11.14M-6.45M
Depreciation Depletion Amortization----------
Non Operating Income---0.03M---0.01M--0.01M--0.02M
Interest Expense----------
AEVI GENOMIC Pretax Income
Provision for Income Taxes----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-8.71M-7.16M-8.61M-8.03M-10.92M-8.48M-10.57M-11.71M-11.14M-6.46M
Extraordinary Items & Discontinued Operations----------
AEVI GENOMIC Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS59.34M55.08M37.11M37.11M37.11M35.16M37.08M33.47M32.95M25.08M
Average Shares used to compute Basic EPS59.34M55.08M37.11M37.11M37.11M35.16M37.08M33.47M32.95M25.02M
Income Before Nonrecurring Items-8.71M-7.16M-8.61M-8.03M-10.92M-8.48M-10.57M-11.71M-11.14M-6.46M
Income from Nonrecurring Items----------
AEVI GENOMIC Earnings Per Share Basic Net
AEVI GENOMIC Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.15-0.13-0.23-0.22-0.29-0.22-0.29-0.35-0.34-0.25
Preferred Dividends Acc Pd----------
Dividends Common0.000.00--------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

It is very helpful to read a report on AEVI GENOMIC stock analysis. An investor must check the following items in an income statement:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: AEVI GENOMIC revenue chart, implies that the company is growing. It has not been the case with AEVI GENOMIC. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-8.71M for GNMX stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called the profit and loss statement. Apart from the GNMX income statement, one can check the AEVI GENOMIC historical stock prices to check how the price has moved with time.

AEVI GENOMIC Income Statement - Key Financial Ratios